Reporting Manager
Stonepine Capital Management, LLC
Symbol
EDSA
Disclosed Ownership
30,000 shares
Ownership
0.3%
Form type
SCHEDULE 13G/A
Filing time
15 May 2026, 17:15:00 UTC
Date of event
31 Mar 2026
Previous filing
25 Feb 2025

Key filing fact

Stonepine Capital Management, LLC disclosed 0.3% ownership in Edesa Biotech, Inc. Common Stock (EDSA) on 31 Mar 2026.

Key facts

  • Stonepine Capital Management, LLC filed SCHEDULE 13G/A for Edesa Biotech, Inc. Common Stock (EDSA).
  • Disclosed ownership: 0.3%.
  • Date of event: 31 Mar 2026.

Change

  • Previous schedule filing date: 25 Feb 2025.
  • Current filing was accepted on 15 May 2026, 17:15.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (4)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Stonepine Capital Management, LLC 0.3% 30,000 0 30,000 /s/ Jon M. Plexico Managing Member
Stonepine Capital, L.P. 0.3% 30,000 0 30,000 /s/ Jon M. Plexico Managing Member of the General Partner, Stonepine GP, LLC
Stonepine GP, LLC 0.3% 30,000 0 30,000 /s/ Jon M. Plexico Managing Member
Jon M. Plexico 0.3% 30,000 0 30,000 /s/ Jon M. Plexico Reporting person
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .